These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 1735343)

  • 41. Evidence for protonation in the human neutrophil formyl peptide receptor binding pocket.
    Fay SP; Domalewski MD; Sklar LA
    Biochemistry; 1993 Feb; 32(6):1627-31. PubMed ID: 8431442
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Fluorescence studies on the binding of a chemotactic peptide to human spermatozoa.
    Shivaji S; Reddy GS; Reddy GL
    Cell Mol Biol (Noisy-le-grand); 1993 Mar; 39(2):171-9. PubMed ID: 8513273
    [TBL] [Abstract][Full Text] [Related]  

  • 43. C- and N-terminal residue effect on peptide derivatives' antagonism toward the formyl-peptide receptor.
    Dalpiaz A; Ferretti ME; Vertuani G; Traniello S; Scatturin A; Spisani S
    Eur J Pharmacol; 2002 Feb; 436(3):187-96. PubMed ID: 11858798
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Strategies for positioning fluorescent probes and crosslinkers on formyl peptide ligands.
    Vilven JC; Domalewski M; Prossnitz ER; Ye RD; Muthukumaraswamy N; Harris RB; Freer RJ; Sklar LA
    J Recept Signal Transduct Res; 1998; 18(2-3):187-221. PubMed ID: 9651885
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Leukocyte inhibitory factor (LIF) potentiates neutrophil responses to formyl-methionyl-leucyl-phenylalanine.
    Borish L; O'Reilly D; Klempner MS; Rocklin RE
    J Immunol; 1986 Sep; 137(6):1897-903. PubMed ID: 3018081
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Metabolism of cysteinyl leukotrienes in non-recirculating rat liver perfusion. Hepatocyte heterogeneity in uptake and biliary excretion.
    Wettstein M; Gerok W; Häussinger D
    Eur J Biochem; 1989 Apr; 181(1):115-24. PubMed ID: 2565811
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Synthesis and use of a novel N-formyl peptide derivative to isolate a human N-formyl peptide receptor cDNA.
    Boulay F; Tardif M; Brouchon L; Vignais P
    Biochem Biophys Res Commun; 1990 May; 168(3):1103-9. PubMed ID: 2161213
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A conformation-activity study of the [L-(alpha Me)Phe]3 analog of the formyl methionyl tripeptide chemoattractant.
    Toniolo C; Crisma M; Pegoraro S; Valle G; Bonora GM; Becker EL; Polinelli S; Boesten WH; Schoemaker HE; Meijer EM
    Pept Res; 1991; 4(2):66-71. PubMed ID: 1815780
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Acylated tripeptides as chemotaxin antagonists (author's transl)].
    Opitz W; Fruchtmann R
    Hoppe Seylers Z Physiol Chem; 1981 Aug; 362(8):1037-41. PubMed ID: 7346374
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The formylpeptide chemotactic receptor on rabbit peritoneal neutrophils. I. Evidence for two binding sites with different affinities.
    Mackin WM; Huang CK; Becker EL
    J Immunol; 1982 Oct; 129(4):1608-11. PubMed ID: 6286772
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Demonstration of receptor-mediated chemotaxis by human spermatozoa. A novel quantitative bioassay.
    Gnessi L; Ruff MR; Fraioli F; Pert CB
    Exp Cell Res; 1985 Nov; 161(1):219-30. PubMed ID: 4054232
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The effect of the cyclopropyl group on the conformation of chemotactic formyl tripeptides.
    Headley AD; Ganesan R; Nam J
    Bioorg Chem; 2003 Apr; 31(2):99-108. PubMed ID: 12729567
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A series of six ligands for the human formyl peptide receptor: tetrapeptides with high chemotactic potency and efficacy.
    Rot A; Henderson LE; Copeland TD; Leonard EJ
    Proc Natl Acad Sci U S A; 1987 Nov; 84(22):7967-71. PubMed ID: 2825171
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The ionic basis of chemotaxis. Separate cation requirements for neutrophil orientation and locomotion in a gradient of chemotactic peptide.
    Marasco WA; Becker EL; Oliver JM
    Am J Pathol; 1980 Mar; 98(3):749-68. PubMed ID: 6767408
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Conformational investigations on analogs of inflammation response inducing chemotactic tripeptide fMLP.
    Rathore RS
    Biopolymers; 2005; 80(5):651-64. PubMed ID: 15648091
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The main functions and structural modifications of tripeptide N-formyl-methionyl-leucyl-phenylalanine (fMLP) as a chemotactic factor.
    Yang KH; Fang H; Ye JS; Gong JZ; Wang JT; Xu WF
    Pharmazie; 2008 Nov; 63(11):779-83. PubMed ID: 19069235
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Superoxide production induced in rabbit polymorphonuclear leukocytes by synthetic chemotactic peptides and A23187.
    Becker EL; Sigman M; Oliver JM
    Am J Pathol; 1979 Apr; 95(1):81-97. PubMed ID: 219701
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of f-Met-Leu-Phe-induced inflammation on intestinal lymph flow and lymphatic pump behavior.
    Benoit JN; Zawieja DC
    Am J Physiol; 1992 Feb; 262(2 Pt 1):G199-202. PubMed ID: 1539654
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Neutral endopeptidase activity in the interaction of N-formyl-L-methionyl-L-leucyl-L-phenylalanine with human polymorphonuclear leukocytes.
    Yuli I; Lelkes PI
    Eur J Biochem; 1991 Oct; 201(2):421-30. PubMed ID: 1935939
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of indomethacin on the binding of the chemotactic peptide formyl-Met-Leu-Phe on human polymorphonuclear leukocytes.
    Cost H; Gespach C; Abita JP
    FEBS Lett; 1981 Sep; 132(1):85-8. PubMed ID: 6271584
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.